Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration

Nephrology

Volumn 11, Issue 5, 2006, Pages 386-393

  Ghani, Rohana Abdul ^a   Zainudin, Soehardy ^a   Ctkong, Norella ^a   Rahman, Ahmad Fauzi Abdul ^a   Wafa, Syed Rozaidi Wafa Syed Hussain ^a   Mohamad, Marlyn ^a   Manaf, Mohd Rizal Abdul ^a   Ismail, Rahimah ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Continuous renal replacement therapy; Continuous venovenous haemofiltration; High volume haemofiltration; IL 1 ra; IL 6; Sequential organ failure assessment

Indexed keywords

AUTACOID; BIOLOGICAL MARKER; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTINUOUS HEMODIAFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HEMOFILTRATION; HIGH VOLUME HEMOFILTRATION; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALE; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASESSMENT SCORE; THERAPY EFFECT; ULTRAFILTRATION;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HEMOFILTRATION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEPSIS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33749127233     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2006.00600.x     Document Type: Article

References (20)

1. Sands KE, Bates DW, Lanken PN et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997; 278: 234-40.
2. Neveu H, Kleinknecht D, Brivet F. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. The French Study Group on Acute Renal Failure. Nephrol. Dial. Transplant. 1996; 11: 293-9.
3. Cohen J. The immunopathogenesis of sepsis. Nature 2002; 420: 885-7.
4. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N. Engl. J. Med. 2003; 348: 138-50.
5. Bone RC, Grodzin CJ, Balk RA. Sepsis: A new pathogenesis of the disease process. Chest 1997; 112: 235-43.
6. Koch T. Mechanisms of sepsis and SIRS. Kidney Int. 1998; 53 (Suppl 64): S66-9.
7. Pinsky MR, Vincent JL, Deviere J. Serum cytokine levels in septic shock - relation to multiple-system organ failure and mortality. Chest 1993; 103: 565-75.
8. McMaster P, Shann F. The use of extracorporeal techniques to remove humoral factors in sepsis. Pediatr. Crit. Care Med. 2003; 4: 2-7.
9. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: A prospective cohort analysis. Intensive Care Med. 1999; 25: 814-21.
10. Ronco C, Bellomo R, Homel P. Effects of different doses in continuous veno-venous hemofiltration on outcomes of acute renal failure: A prospective randomized trial. Lancet 2000; 356: 26-30.
11. Cole L, Bellomo R, Journois D. High-volume haemofiltration in human septic shock. Intensive Care Med. 2001; 27: 978-86.
12. Bouman SC, Oudemans-van Straaten HM, Tijssen JGP. Effects of early high volume CVVHF on survival and recovery of renal function in ICU patients with ARF: A prospective, randomized trial. Crit. Care Med. 2002; 30: 2205-11.
13. Vincent JL, de Mendonça A, Cantraine F. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicentric, prospective study. Crit. Care Med. 1998; 26: 1793.
14. Fauzi AR, Soehardy Z, Jeyabalan V. High volume haemofiltration (HVHF) for sepsis: An early experience in a single centre. Nephro-Asia 2004; 9-12 Feb.
15. Sehgal PB, Greininger G, Tosato G. Regulation of the acute phase and immune responses: Interleukin-6. Ann. NY Acad. Sci. 1989; 557: 1-583.
16. De Vriese AS, Colardyn FA, Philippe JJ et al. Cytokine removal during continuous veno-venous hemofiltration in septic patients. J. Am. Soc. Nephrol. 1999; 10: 846-53.
17. Heering P, Morgera S, Schmitz G. Cytokine removal and cardiovascular haemodynamics in septic patients with continuous venovenous hemofiltration. Intensive Care Med. 1997; 23: 878-84.
18. Brendolan A, Bellomo R, Tetta C. Coupled plasma filtration-adsorption technique in the treatment of septic shock. In: Ronco C, Bellomo R, la Greca G (eds). Blood Purification in Intensive Care. Vol. 132. Basel: Karger, 2001; 383-90.
19. Tetta C, Bellomo R, Inguaggiato P. Endotoxin and cytokine removal in sepsis. Therap. Apher. 2002; 6: 109-15.
20. Kikuchi H, Maruyama H, Omori S. The sequential organ failure assessment score as a useful predictor for estimating the prognosis of SIRS patients being treated with extracorporeal blood purification. Therap. Apher. Dial. 2003; 7: 456-60.